Peter Matthew Lynch
Impact in
-
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Treatment and Management
- Diabetes Management and Education
-
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Papers in
-
- Diabetes Management and Research 17
- Diabetes Treatment and Management 4
- Genetics 5
- Diabetes and associated disorders 5
- Co-authors
- Stéphane Roze (10 shared papers)John J. Isitt (7 shared papers)Gregory J. Norman (6 shared papers)Jayne Smith‐Palmer (4 shared papers)Eileen M. Moore (1 shared paper)Daniel Flanagan (1 shared paper)Donald S. Wright (1 shared paper)Claudia Graham (2 shared papers)
- Journals
- Value in Health (3 papers)Diabetes (2 papers)Diabetic Medicine (2 papers)Heliyon (2 papers)Diabetes Therapy (2 papers)
- Partner nations
- United StatesIrelandAustralia
In The Last Decade
Peter Matthew Lynch
30 papers receiving 419 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 264
- Neurology 43
- Genetics 71
- Surgery 80
- Geriatrics and Gerontology 5
Countries citing papers authored by Peter Matthew Lynch
This map shows the geographic impact of Peter Matthew Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Matthew Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Matthew Lynch more than expected).
Fields of papers citing papers by Peter Matthew Lynch
This network shows the impact of papers produced by Peter Matthew Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Matthew Lynch. The network helps show where Peter Matthew Lynch may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Matthew Lynch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 66 | |
| 2 | 2018 | 48 | |
| 3 | 2008 | 40 | |
| 4 | 2020 | 40 | |
| 5 | 2022 | 32 | |
| 6 | 2022 | 27 | |
| 7 | 2020 | 22 | |
| 8 | Resource utilization with insulin pump therapy for type 2 diabetes mellitus. | 2010 | 18 |
| 9 | 2022 | 18 | |
| 10 | 2021 | 13 | |
| 11 | 2023 | 13 | |
| 12 | 2023 | 13 | |
| 13 | 2010 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2023 | 9 | |
| 18 | 2024 | 9 | |
| 19 | 2019 | 7 | |
| 20 | 2021 | 6 |
About Peter Matthew Lynch
Peter Matthew Lynch is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Psychiatry and Mental health, Neurology and Rehabilitation, having authored 32 papers that have together received 441 indexed citations. Recurring topics across this work include Diabetes Management and Research (17 papers), Diabetes and associated disorders (5 papers), Diabetes Treatment and Management (4 papers), Pancreatic function and diabetes (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Neurological disorders and treatments (2 papers), Stroke Rehabilitation and Recovery (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (264 citations), Neurology (43 citations), Genetics (71 citations), Surgery (80 citations) and Geriatrics and Gerontology (5 citations). Peter Matthew Lynch has collaborated with scholars based in United States, Ireland and Australia. Frequent co-authors include Stéphane Roze, John J. Isitt, Gregory J. Norman, Jayne Smith‐Palmer, Eileen M. Moore, Daniel Flanagan, Donald S. Wright, Claudia Graham, Michael E. Minshall and Katya E. Kotschet. Their work appears in journals such as Value in Health, Diabetes, Diabetic Medicine, Heliyon and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.